minoxidil has been researched along with diphenylcyclopropenone in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Orecchia, G; Rabbiosi, G | 1 |
| De Padova, MP; Minghetti, G; Tosti, A; Veronesi, S | 1 |
| Ho, V; Shapiro, J; Tan, J; Tron, V | 1 |
| Abbott, F; Ho, V; Shapiro, J; Tan, J; Tron, V | 1 |
| Burkhart, CN; Morrell, DS; Mukherjee, N | 1 |
| Alkhalifah, A; Alsantali, A; McElwee, KJ; Shapiro, J; Wang, E | 1 |
| Aljuffali, IA; Fang, JY; Huang, CT; Shen, FM; Sung, CT | 1 |
| Shapiro, J | 1 |
| Perera, E; Sinclair, R; Yip, L | 1 |
| Wolff, H | 1 |
| Fabi, SG; Zaleski-Larsen, LA | 1 |
| Bergfeld, W; Murad, A | 1 |
| Bennouna-Dalero, T; Correa-Pérez, A; Fernández-García, S; Gaetano Gil, A; Giraldo, L; Mateos-Haro, M; Novoa-Candia, M; Ortega-Quijano, D; Saceda-Corralo, D; Sánchez Vanegas, G; Tomlinson, J; Urueña Rodriguez, MG; Vaño-Galván, S; Zamora, J | 1 |
7 review(s) available for minoxidil and diphenylcyclopropenone
| Article | Year |
|---|---|
Treatment of alopecia areata in children.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Alopecia Areata; Anthralin; Child; Child, Preschool; Cyclobutanes; Cyclopropanes; Dermatologic Agents; Dinitrochlorobenzene; Glucocorticoids; Humans; Immunosuppressive Agents; Immunotherapy; Minoxidil; Phototherapy; Practice Guidelines as Topic; Treatment Outcome; Vasodilator Agents | 2009 |
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropanes; Cyclosporine; Hair; Haptens; Humans; Immunotherapy; Injections, Intralesional; Laser Therapy; Methotrexate; Minoxidil; Photochemotherapy; Randomized Controlled Trials as Topic; Rats; Recurrence; Research Design; Social Support; Sulfasalazine; Treatment Outcome; Triamcinolone Acetonide | 2010 |
Current treatment of alopecia areata.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Alopecia Areata; Anthralin; Cyclobutanes; Cyclopropanes; Cyclosporine; Dermatologic Agents; Humans; Immunosuppressive Agents; Injections, Intralesional; Methotrexate; Minoxidil; PUVA Therapy; Self-Help Groups | 2013 |
Alopecia areata.
Topics: Administration, Topical; Adrenal Cortex Hormones; Alopecia Areata; Anthralin; Autoimmunity; Cyclopropanes; Cyclosporine; Dermatitis, Allergic Contact; Dermatologic Agents; Humans; Immunosuppressive Agents; Immunotherapy; Injections, Intralesional; Minoxidil; Vasodilator Agents | 2015 |
Laser-Assisted Drug Delivery.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Aminolevulinic Acid; Aminoquinolines; Analgesics; Antibodies; Antineoplastic Agents; Ascorbic Acid; Cyclopropanes; Dermatologic Agents; Drug Delivery Systems; Fluorouracil; Humans; Imiquimod; Immunotherapy; Laser Therapy; Methotrexate; Minoxidil; Permeability; Photosensitizing Agents; Polyesters; RNA, Small Interfering; Skin; Timolol; Vaccines | 2016 |
Treatment for facial alopecia areata: A systematic review with evidence-based analysis.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Alopecia Areata; Anthralin; Bimatoprost; Cyclopropanes; Dermatologic Agents; Drug Therapy, Combination; Eyebrows; Eyelashes; Facial Dermatoses; Humans; Latanoprost; Minoxidil; Photosensitizing Agents; Prostaglandins F, Synthetic | 2018 |
Treatments for alopecia areata: a network meta-analysis.
Topics: Adolescent; Adult; Aged; Alopecia Areata; Betamethasone; Biological Products; Child; Child, Preschool; Cyclosporins; Humans; Immunosuppressive Agents; Middle Aged; Minoxidil; Network Meta-Analysis; Prednisolone; Young Adult | 2023 |
3 trial(s) available for minoxidil and diphenylcyclopropenone
| Article | Year |
|---|---|
Therapies versus placebo in the treatment of patchy alopecia areata.
Topics: Adolescent; Adult; Age Factors; Aged; Alopecia Areata; Child; Child, Preschool; Clinical Trials as Topic; Cyclobutanes; Cyclopropanes; Female; Humans; Male; Middle Aged; Minoxidil; Placebos | 1986 |
Treatment of severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation.
Topics: Administration, Cutaneous; Alopecia Areata; Cyclopropanes; Double-Blind Method; Drug Combinations; Gene Expression; Hair; Humans; Intercellular Adhesion Molecule-1; Langerhans Cells; Minoxidil; Placebos; T-Lymphocytes | 1995 |
Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation.
Topics: Administration, Cutaneous; Adult; Aged; Alopecia; Antibodies, Monoclonal; Antigens, CD; CD4 Antigens; CD8 Antigens; Cell Adhesion Molecules; Chronic Disease; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunophenotyping; Intercellular Adhesion Molecule-1; Keratinocytes; Langerhans Cells; Male; Middle Aged; Minoxidil; Severity of Illness Index; T-Lymphocyte Subsets | 1993 |
3 other study(ies) available for minoxidil and diphenylcyclopropenone
| Article | Year |
|---|---|
Patterns of hair regrowth in alopecia areata.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Alopecia Areata; Child; Cyclobutanes; Cyclopropanes; Female; Hair; Humans; Male; Minoxidil | 1988 |
Squarticles as a lipid nanocarrier for delivering diphencyprone and minoxidil to hair follicles and human dermal papilla cells.
Topics: Animals; Cells, Cultured; Cyclopropanes; Drug Carriers; Drug Delivery Systems; Female; Hair Follicle; Humans; Mice; Mice, Nude; Microscopy, Confocal; Microscopy, Fluorescence; Minoxidil; Nanoparticles; Sebum; Skin Irritancy Tests; Vascular Endothelial Growth Factor A; Vasodilator Agents | 2014 |
[Drug treatment of alopecia].
Topics: Administration, Topical; Adrenal Cortex Hormones; Alopecia; Anti-Bacterial Agents; Cyclopropanes; Evidence-Based Medicine; Finasteride; Humans; Minoxidil; Treatment Outcome | 2015 |